• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Pride
    / Unipharm

    Active Ingredient
    Amisulpride 100 mg, 400 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    30 X 100 mg

    full basket chart 42441

    Film Coated Tablets

    30 X 400 mg

    full basket chart 33002

    Related information


    Predominantly negative episodes: Doses between 50 mg/day and 300 mg/day are recommended. Doses should be adjusted individually. The optimum dosage is about 100 mg/day. For patients with mixed positive and negative symptoms, doses should be adjusted to obtain optimal control of positive symptoms.
    Acute psychotic episodes: Initiating treatment: It is possible to start via the IM route for a few days, at a maximum dose of 400 mg/day, switching thereafter to oral treatment. Oral doses between 400 mg/day and 800 mg/day are recommended. The maximum dose should never exceed 1200 mg. Given that there has been no large-scale safety assessment of doses higher than 1200 mg/day, these doses should not be used.      


    Treatment of schizophrenia.


    Hypersensitivity to active substance of its ingredients. Presence of  pheochromocytoma. Patients under the age of 15. Lactation. Women of child-bearing age, unless they are using proper contraceptives. Patients with prolactin-dependent tumor, for example, a pituitary tumor or breast cancer.
    Concomitant use with: anti- parkinsonian drugs (e.g., amantadine, apomorphine, bromocriptine, entacapone, lisuride, pergolide, piribedil, pramipexole, rasagiline, ropinirole, rotigotine, selegiline).
    Concomitant use with: drugs that affect heart rate (e.g., torsades de pointes, class Ia antiarrhythmics, such as quinidine, hydroquinidine, disopyramide, and class III antiarrhythmics, such as amiodarone, dronedarone, sotalol, dofetilide, ibutilide).
    Concomitant use with: chlorpromazine, cyamemazine, droperidol, flupenthixol, fluphenazine, haloperidol, levomepromazine, pimozide, pipamperone, pipotiazine, sertindole, sulpiride, sultopride, tiapride, zuclopenthixol.
    Concomitant use with: halofantrine, lumefantrine, pentamidine, methadone. addiction to certain drugs.
    Concomitant use with: arsenic compounds, bepridil, cisapride, diphemanil, dolasetron IV, erythromycin IV, mizolastine, vincamine IV, domperidone, levofloxacin, mequitazine, vandetanib, moxifloxacin, spiramycin IV, toremifene, alcohol.

    Special Precautions

    Please refer to the license holder for further details.

    Side Effects

    Please refer to the license holder for further details.

    Drug interactions

    Please refer to the license holder for further details.

    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Please refer to the license holder for further details.

    Important notes

    Lactose: contains lactose.

    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel